FIELD: medicine, oncology, pharmacy.
SUBSTANCE: invention relates to drugs, in particular, to a pharmaceutical composition used in treatment of breast cancer. Pharmaceutical composition comprises bisphosphonate, COX-2 inhibitor and taxotere for simultaneous, successive or separate using wherein bisphosphonate represents 2-(imidazol-1-yl)-1-hydroxyethane-1,1-diphosphonic acid (zolendronic acid) or its pharmacologically acceptable salt and wherein compound SC236 represents inhibitor of COX-2.
EFFECT: valuable medicinal properties of pharmaceutical composition.
2 cl, 20 tbl, 21 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR APPLYING CYCLOOXYGENASE-2 INHIBITOR FOR TREATMENT AND PROPHYLAXIS OF NEOPLASIA | 1997 |
|
RU2239429C2 |
| 2-CYCLOOXYGENASE INHIBITORS AS ANTIANGIOGENIC AGENTS | 1997 |
|
RU2268716C2 |
| NOVEL HETEROCYCLES | 2009 |
|
RU2572616C2 |
| METHOD FOR TREATING INFLAMMATION OR INFLAMMATION-INDUCED DISEASE IN DOGS | 1996 |
|
RU2253456C2 |
| COMPOUNDS AND COMPOSITIONS AS ITPKb INHIBITORS | 2007 |
|
RU2425826C2 |
| MORPHOLINYL PYRIDONES | 2018 |
|
RU2803158C2 |
| TRIAZOLOPYRIDINE JAK INHIBITOR COMPOUNDS AND METHODS | 2009 |
|
RU2561104C2 |
| PYRAZOLYL-SUBSTITUTED BENZENESULFONEAMIDE OR ITS PHARMACEUTICALLY ACCEPTABLE SALT, METHOD OF TREATMENT OF PATIENTS WITH INFLAMMATION OR INFLAMMATION-ASSOCIATED DISEASES | 1994 |
|
RU2139281C1 |
| DERIVATIVES OF N-(1,5-DIPHELYL-1H-PYRAZOL-3-YL)SULPHONAMIDE WITH AFFINITY TO CB RECEPTORS | 2005 |
|
RU2366657C2 |
| DERIVATIVES OF PYRAZOLINE, METHODS FOR THEIR PREPARING AND PHARMACEUTICAL COMPOSITION | 1999 |
|
RU2233272C2 |
